Published in Cancer Res on September 01, 2001
Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res (2007) 1.43
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model. Gut (2007) 1.08
Directing dendritic cell immunotherapy towards successful cancer treatment. Immunotherapy (2010) 1.04
Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biol Proced Online (2003) 0.97
Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation. Immunology (2003) 0.97
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model. Cancer Immunol Immunother (2010) 0.90
Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. New J Sci (2014) 0.85
The immunotherapeutic effect of dendritic cells vaccine modified with interleukin-18 gene and tumor cell lysate on mice with pancreatic carcinoma. World J Gastroenterol (2002) 0.85
Prospects for immunotherapy of malignant disease. Clin Exp Immunol (2003) 0.85
Bridging innate and adaptive antitumor immunity targeting glycans. J Biomed Biotechnol (2010) 0.84
Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer. Can J Gastroenterol (2008) 0.83
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells? Oncoimmunology (2013) 0.83
Differential functional effects of biomaterials on dendritic cell maturation. Acta Biomater (2012) 0.83
Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivo. World J Gastroenterol (2008) 0.83
Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate. Int J Biol Sci (2010) 0.82
Dendritic cell-based immunotherapy. Cell Res (2016) 0.81
T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy? Br J Cancer (2002) 0.81
Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy. Clin Dev Immunol (2010) 0.81
Down-regulation of beta-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study. J Cancer Res Clin Oncol (2007) 0.80
Monitoring of CD4+ and CD8+ T-cell responses after dendritic cell-based immunotherapy using CFSE dye dilution analysis. J Clin Immunol (2004) 0.79
Tumor lysate-loaded biodegradable microparticles as cancer vaccines. Expert Rev Vaccines (2014) 0.79
Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells. Oncotarget (2016) 0.76
Endoscopic ultrasound-fine needle injection for oncological therapy. World J Gastrointest Oncol (2015) 0.75
Cancer vaccine development: designing tumor cells for greater immunogenicity. Front Biosci (Landmark Ed) (2010) 0.75
Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models. Chin J Cancer (2012) 0.75
Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors. Oncol Rep (2015) 0.75
Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells. J Biomed Mater Res A (2014) 0.75
Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells. Yonsei Med J (2014) 0.75
Implication of caspase-3 and granzyme B expression and activity in spleenocytes of ehrlich ascites carcinoma mice subjected to immunotherapy. N Am J Med Sci (2011) 0.75
Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticles. Nanomedicine (Lond) (2015) 0.75
Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol (2001) 3.64
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol (1994) 3.51
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol (2001) 3.34
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis (1990) 3.20
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A (2005) 2.75
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol (1999) 2.52
The GroE chaperonin machine is a major modulator of the CIRCE heat shock regulon of Bacillus subtilis. EMBO J (1997) 2.50
Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol (2001) 2.16
High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine (2000) 1.92
Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83
Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells. Eur J Immunol (1989) 1.72
Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol (1988) 1.70
The activation of female sex hormones: alpha-Oestradiol and its di-esters. Biochem J (1938) 1.69
C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med (1988) 1.67
Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr (1991) 1.57
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology (1993) 1.56
The activation of female sex hormones: Oestrone and its esters. The output of activity and efficiency coefficient. Biochem J (1938) 1.49
Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry. Horm Metab Res (2010) 1.42
C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. J Immunol (1987) 1.41
Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther (2001) 1.40
[Fish oil to prevent recurrence of Crohn disease?]. Z Gastroenterol (1997) 1.39
Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J Immunol (1988) 1.37
Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today (1997) 1.34
Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol (2000) 1.31
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab (2009) 1.30
Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol (1998) 1.30
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J Leukoc Biol (2001) 1.30
Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol (2000) 1.29
The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. Int J Immunopharmacol (1993) 1.23
Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci (2000) 1.22
Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Res (1988) 1.22
Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat (2006) 1.21
Development and use of a radioimmunoassay for human interleukin-1 beta. Lymphokine Res (1987) 1.21
Modular structure of the trigger factor required for high activity in protein folding. J Mol Biol (1997) 1.21
In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology (1992) 1.20
Slit-lamp-adapted optical coherence tomography of the anterior segment. Graefes Arch Clin Exp Ophthalmol (2000) 1.19
Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J Pharmacol Exp Ther (2000) 1.19
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell (1997) 1.18
Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole. Infection (1994) 1.16
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis (2005) 1.15
Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary artery. Br J Ophthalmol (2006) 1.13
In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination. J Infect Dis (1998) 1.11
Dynamic association of trigger factor with protein substrates. J Mol Biol (2001) 1.11
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model. Gut (2007) 1.08
Corneal optical coherence tomography before and immediately after excimer laser photorefractive keratectomy. Am J Ophthalmol (2000) 1.08
Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN. J Leukoc Biol (2002) 1.06
Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand J Immunol (1997) 1.03
Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol (1997) 1.02
Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem (2001) 1.00
Tracer test with As(V) under variable redox conditions controlling arsenic transport in the presence of elevated ferrous iron concentrations. J Contam Hydrol (2006) 0.99
Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Eur J Immunol (2001) 0.98
An empirical verification of population assignment methods by marking and parentage data: hatchery and wild steelhead (Oncorhynchus mykiss) in Forks Creek, Washington, USA. Mol Ecol (2006) 0.98
Cyclophilin and trigger factor from Bacillus subtilis catalyze in vitro protein folding and are necessary for viability under starvation conditions. Biochemistry (1998) 0.97
New bioresorbable pin for the reduction of small bony fragments: design, mechanical properties and in vitro degradation. Biomaterials (1996) 0.96
Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol Dial Transplant (1995) 0.95
Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur J Immunol (1995) 0.95
First experimental and clinical results with transscleral optical coherence tomography. Ophthalmic Surg Lasers (2000) 0.95
[Spectrum of diagnoses in an internal medicine emergency unit]. Internist (Berl) (2001) 0.94
Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss. J Reprod Immunol (2010) 0.94
The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Chest (1996) 0.94
Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg (1993) 0.94
Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. J Leukoc Biol (1992) 0.93
Spread of HIV-2 in India. Lancet (1991) 0.93
Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J Immunol (1995) 0.92
Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination. Clin Exp Immunol (2001) 0.92
Functions of FKBP12 and mitochondrial cyclophilin active site residues in vitro and in vivo in Saccharomyces cerevisiae. Mol Biol Cell (1997) 0.92
Crystal structure of a phage library-derived single-chain Fv fragment complexed with turkey egg-white lysozyme at 2.0 A resolution. J Mol Biol (2000) 0.91
Subhemolytic doses of Escherichia coli hemolysin evoke large quantities of lipoxygenase products in human neutrophils. J Biol Chem (1991) 0.90
[Examination of the cornea using optical coherence tomography]. Ophthalmologe (2001) 0.90
A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin. Lymphokine Res (1988) 0.88
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut (1997) 0.88
Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria. Blood (1995) 0.88
Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. AIDS (1995) 0.87
Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin. Mol Med (1996) 0.87
Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. J Immunol (1997) 0.87
No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome. J Clin Immunol (2005) 0.87
The activation of female sex hormones: Mono-esters of alpha-oestradiol. Biochem J (1938) 0.86
Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction. Arch Gynecol Obstet (2008) 0.86
Interleukin-1, anorexia, and dietary fatty acids. Ann N Y Acad Sci (1990) 0.85
Primary hyperparathyroidism presenting with acute paraplegia. AJR Am J Roentgenol (1977) 0.85
The glycoinositolphospholipids from Leishmania panamensis contain unusual glycan and lipid moieties. J Mol Biol (1998) 0.85
[Endoscopic-controlled laser lithotripsy of salivary calculi. In vitro studies and initial clinical use]. HNO (1990) 0.84
Structural studies of oligonucleotides containing G-quadruplex motifs using AFM. Biochem Biophys Res Commun (2004) 0.84
Do we need gastric acid? Digestion (2008) 0.84
Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg (1993) 0.84